|
시장보고서
상품코드
1630667
유전자 발현 분석 시장 규모, 점유율, 성장 분석 : 제품별, 프로세스별, 용량별, 방법별, 용도별, 지역별 - 산업 예측(2025-2032년)Gene Expression Analysis Market Size, Share, Growth Analysis, By Product (Reagents & Consumables, Instruments), By Process (Sample Collection, Purification), By Capacity, By Technique, By Application, By Region - Industry Forecast 2025-2032 |
||||||
세계의 유전자 발현 분석 시장 규모는 2023년에 48억 달러로 평가되며, 2024년 52억 달러에서 2032년에는 99억 2,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.4%로 성장할 전망입니다.
세계의 유전자 발현 분석 시장은 맞춤의료 및 정밀치료에 대한 수요 증가에 힘입어 크게 성장할 것으로 예상됩니다. 이 시장은 임상의가 특정 질병과 관련된 고유한 유전자 시그니처를 식별하여 표적 치료를 촉진할 수 있도록 돕습니다. 차세대 시퀀싱(NGS) 및 마이크로어레이 기술의 발전으로 분석의 효율성과 비용 효율성이 향상되어 연구자들은 방대한 데이터세트를 관리하고 주요 유전자 조절 네트워크를 밝힐 수 있게 되었습니다. 암, 심혈관 질환과 같은 만성질환의 발병률이 증가함에 따라 바이오마커 발굴 및 치료법 개발에 있으며, 유전자 발현 분석의 필요성이 증가하고 있습니다. 그러나 복잡한 데이터 분석, 숙련된 바이오인포매틱스 전문가 부족, 높은 기술 활용 비용 등의 문제는 시장 잠재력을 최적화하고 모든 분야에서 폭넓게 채택될 수 있도록 해결해야 할 과제입니다.
Global Gene Expression Analysis Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.2 billion in 2024 to USD 9.92 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).
The global gene expression analysis market is poised for significant growth, fueled by the rising demand for personalized medicine and precision therapies. This market enables clinicians to identify unique gene signatures linked to specific diseases, thereby facilitating targeted treatments. Advances in next-generation sequencing (NGS) and microarray technologies have made analysis more efficient and cost-effective, allowing researchers to manage extensive datasets and uncover key gene regulatory networks. The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, heightens the need for gene expression analysis in biomarker discovery and therapeutic development. However, challenges like complex data interpretation, a shortage of skilled bioinformatics professionals, and the high costs of technology utilization must be addressed to optimize market potential and ensure broader adoption across settings.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Expression Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Gene Expression Analysis Market Segmental Analysis
Global Gene Expression Analysis Market is segmented by Product, Process, Capacity, Technique, Application and region. Based on Product, the market is segmented into Reagents & Consumables, Instruments and Service. Based on Process, the market is segmented into Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation and Others. Based on Capacity, the market is segmented into Low- to Mid- Plex and High-Plex. Based on Technique, the market is segmented into RNA Expression, Promoter Analysis and Protein Expression & Posttranslational Modification Analysis. Based on Application, the market is segmented into Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Gene Expression Analysis Market
The Global Gene Expression Analysis market is significantly propelled by the escalating incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders. This trend underscores the necessity of gene expression analysis as it facilitates a deeper understanding of the molecular mechanisms associated with these conditions. Such insights are essential for enabling early diagnosis, enhancing treatment strategies, and advancing drug discovery efforts. Consequently, the growing need for innovative diagnostic and therapeutic solutions to combat these widespread health challenges is fostering a robust demand for gene expression analysis technologies in the market, ultimately driving its expansion and evolution.
Restraints in the Global Gene Expression Analysis Market
The Global Gene Expression Analysis market faces several restraints, primarily stemming from ethical and regulatory challenges. Concerns regarding the ethical use of genomic data, along with stringent regulations surrounding data privacy and protection, can hinder market growth. Adhering to data privacy laws, obtaining informed consent, and aligning research practices with ethical standards for managing patient information present significant obstacles for both researchers and companies in the gene expression analysis sector. As a result, the complexities associated with compliance may slow innovation and implementation within the market, ultimately impacting its overall development and expansion.
Market Trends of the Global Gene Expression Analysis Market
The Global Gene Expression Analysis market is increasingly dominated by the trend of single-cell gene expression analysis, driven by advancements in microfluidics, isolation methods, and sequencing technologies. This innovative approach empowers researchers to delve into cellular heterogeneity, identify rare cell populations, and observe dynamic gene expression changes at the individual cell level. This granular understanding is crucial for applications across developmental biology, cancer research, and precision medicine, enhancing drug discovery and therapeutic strategies. As the demand for more precise genetic insights continues to grow, the single-cell analysis segment is poised to significantly influence the market landscape in the coming years.